(603367)"Cisen Pharmaceutical Co., Ltd."Announcement on Change of Sponsor Representative
Filed with SSE · Stock code 603367 · · 2 pages · Chinese
Summary by 6ix AI
The previous representative, Mr. Suo Jianpeng, has been replaced by Mr. Zhan Ruichao due to a job change.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/603367cisen-pharmaceutical-co-ltdannouncement-on-change-of-sponsor-representative
Cisen Pharmaceutical Ltd. on 6ix
Story so far
- (603367)"Cisen Pharmaceutical Co., Ltd."Announcement on Resolutions of the 15th Meeting of the 5th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops
Earlier from Cisen Pharmaceutical
- (603367)"Cisen Pharmaceutical Co., Ltd."Report for Q3 2026
- (603367)"Cisen Pharmaceutical Co., Ltd."Announcement on Resolutions of the 15th Meeting of the 5th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
Follow Cisen Pharmaceutical into a list and get an email when it puts out news.
Follow Cisen Pharmaceutical